Five Upcoming Startup Events In Delhi

March 29, 2017 Vijay Soni 0

Five Upcoming Startup Events In Delhi By: Vijay Soni, PhD | Founder & C.E.O. Scipreneur (1) Startups Founders & Investors Meet Sat, 22 Apr 2017    12:00PM – 3:00PM By Eduwhiz .in at WorkWings , Delhi Rs 500 Description Eduwhiz brings Startup Founders & Investors 3.0. Applications open for Startups at Please [..]

Microscopes from droplets: MIT Research

March 25, 2017 Vijay Soni 0

Microscopes from droplets: MIT Research Source: Jennifer Chu | MIT News Office March 25, 2017 Liquid droplets are natural magnifiers. Look inside a single drop of water, and you are likely to see a reflection of the world around you, close up and distended as you’d see in a crystal [..]

FDA Approves Xadago® (Safinamide) For Parkinson’s Disease

March 23, 2017 Vijay Soni 0

FDA Approves Xadago® (Safinamide) For Parkinson’s Disease By: Newron Pharmaceuticals News March 23, 2017  Newron Pharmaceuticals S.p.A. (“Newron”, SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, and its partners Zambon S.p.A. and US WorldMeds, [..]

FDA Approved Lexicon Pharma’s Xermelo® Against Carcinoid Syndrome Diarrhea

March 9, 2017 Vijay Soni 0

FDA Approved Lexicon Pharma’s Xermelo® Against Carcinoid Syndrome Diarrhea Source: FDA News and Lexpharma News March 9, 2017 The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled. Carcinoid [..]

GSK’s MUSCA Study Shows Nucala® Found Significantly Effective In Severe Asthma Patients

March 7, 2017 Vijay Soni 0

GSK’s MUSCA Study Shows Nucala® Found Significantly Effective In Severe Asthma Patients Issued From: London UK – LSE Announcement GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and [..]

Roche’s Perjeta® Regimen For Breast Cancer Found to Greatly Extend Patients’ Lives: Phase III APHINITY study

March 7, 2017 Vijay Soni 0

Roche’s Perjeta® Regimen For Breast Cancer Found to Greatly Extend Patients’ Lives: Phase III APHINITY study By: Basel Roche News Perjeta plus Herceptin and chemotherapy showed a statistically significant improvement in invasive disease-free survival (iDFS) for people with HER2-positive early breast cancer (eBC) compared to Herceptin and chemotherapy alone Data will be discussed with [..]

Drug Treatment Could Combat Hearing Loss

March 5, 2017 Vijay Soni 0

Drug Treatment Could Combat Hearing Loss By: Anne Trafton | MIT News Office March 05, 2017 Within the inner ear, thousands of hair cells detect sound waves and translate them into nerve signals that allow us to hear speech, music, and other everyday sounds. Damage to these cells is one [..]

Tiny Fibers Open New Windows Into The Brain

March 5, 2017 Vijay Soni 0

Tiny Fibers Open New Windows Into The Brain March 05, 2017 David L. Chandler | MIT News Office For the first time ever, a single flexible fiber no bigger than a human hair has successfully delivered a combination of optical, electrical, and chemical signals back and forth into the brain, [..]

Startup Events In USA : March 2017

March 2, 2017 Vijay Soni 0

Startup Events In USA : March 2017 By: Vijay Soni, PhD | Founder & C.E.O. Scipreneur Whether you are starting a business just now, or you are already running a company, or you are just curious about what might be the business, entrepreneurship, technology, or digital marketing trends of tomorrow, [..]